Sparfloxacin versus cefaclor in the treatment of patients with community-acquired pneumonia: a randomized, double-masked, comparative, multicenter study.

[1]  Sheldon P Stone,et al.  Community-acquired pneumonia , 1998, The Lancet.

[2]  P. Saikku,et al.  Oral empiric treatment of community-acquired pneumonia. A multicenter, double-blind, randomized study comparing sparfloxacin with roxithromycin. The Scandinavian Sparfloxacin Study Group. , 1996, Chest.

[3]  R. Peeling,et al.  Ambulatory patients with community-acquired pneumonia: the frequency of atypical agents and clinical course. , 1996, The American journal of medicine.

[4]  G. Talbot,et al.  Overview of electrocardiographic and cardiovascular safety data for sparfloxacin. Sparfloxacin Safety Group. , 1996, The Journal of antimicrobial chemotherapy.

[5]  D. Honeybourne,et al.  A review of the penetration of sparfloxacin into the lower respiratory tract and sinuses. , 1996, The Journal of antimicrobial chemotherapy.

[6]  H. Portier,et al.  Comparative efficacy of sparfloxacin in comparison with amoxycillin plus ofloxacin in the treatment of community-acquired pneumonia. French Study Group. , 1996, The Journal of antimicrobial chemotherapy.

[7]  W. Wijnands,et al.  Sparfloxacin for the treatment of community-acquired pneumonia: a pooled data analysis of two studies. , 1996, The Journal of antimicrobial chemotherapy.

[8]  H. Lode,et al.  Treatment of community-acquired pneumonia: a randomized comparison of sparfloxacin, amoxycillin-clavulanic acid and erythromycin. , 1995, The European respiratory journal.

[9]  G. Mccracken,et al.  Management of infections caused by antibiotic-resistant Streptococcus pneumoniae. , 1994, The New England journal of medicine.

[10]  F. Tenover,et al.  Emergence of drug-resistant pneumococcal infections in the United States. , 1994, JAMA.

[11]  M. Kaku,et al.  In vitro and in vivo activities of sparfloxacin against Mycoplasma pneumoniae , 1994, Antimicrobial Agents and Chemotherapy.

[12]  V L Yu,et al.  Guidelines for the initial management of adults with community-acquired pneumonia: diagnosis, assessment of severity, and initial antimicrobial therapy. American Thoracic Society. Medical Section of the American Lung Association. , 1993 .

[13]  D. Barnes.  Microbial etiology of acute pneumonia in hospitalized patients. , 1993, Chest.

[14]  Y. Niki,et al.  In vitro and in vivo antichlamydial activities of newly developed quinolone antimicrobial agents , 1993, Antimicrobial Agents and Chemotherapy.

[15]  L. Reller,et al.  Ofloxacin, a new broad-spectrum fluoroquinolone. Results from a Multicenter, National Comparative Activity Surveillance Study. The Ofloxacin Surveillance Group. , 1992, Diagnostic microbiology and infectious disease.

[16]  N. Klein.  Fluoroquinolones in respiratory infections. , 1991, Seminars in respiratory infections.

[17]  A. Barry,et al.  In vitro activities of sparfloxacin, tosufloxacin, ciprofloxacin, and fleroxacin , 1991, Antimicrobial Agents and Chemotherapy.

[18]  W. Kapoor,et al.  New and Emerging Etiologies for Community‐Acquired Pneumonia with Implications for Therapy: A Prospective Multicenter Study of 359 Cases , 1990, Medicine.

[19]  D. Kaiser,et al.  Prediction of microbial aetiology at admission to hospital for pneumonia from the presenting clinical features. British Thoracic Society Pneumonia Research Subcommittee. , 1989, Thorax.

[20]  T. Marrie,et al.  Community-acquired pneumonia requiring hospitalization: 5-year prospective study. , 1989, Reviews of infectious diseases.

[21]  T. Marrie,et al.  Community‐Acquired Pneumonia Requiring Hospitalization , 1985, Journal of the American Geriatrics Society.

[22]  W. Marine,et al.  Bacterial pneumonia during the Hong Kong influenza epidemic of 1968-1969. , 1971, Archives of internal medicine.

[23]  A. Malmborg,et al.  In vitro activity of sparfloxacin compared with ciprofloxacin and ofloxacin against respiratory tract pathogens. , 1993, Chemotherapy.

[24]  J T Macfarlane,et al.  Comparative clinical and laboratory features of legionella with pneumococcal and mycoplasma pneumonias. , 1987, British journal of diseases of the chest.